Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban PK/PD in Obese Bariatric Surgery Patients
NCT02438098Phase 1Completed
- Sponsor
- Insel Gruppe
- Start
- Jun 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of rivaroxaban in venous thromboembolism (VTE), sponsored by Insel Gruppe. Primary endpoint: Geometric mean ratio of rivaroxaban AUC (after surgery / before surgery). Started Jun 2015; status: completed.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02438098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02438098.